MEDICA is a provider of long- and short-term dependency care in France. It operates both in the long-term care sector, with nursing homes in France and Italy, and in the post- acute and psychiatric care sector. MEDICA has been listed on the NYSE Euronext Paris stock exchange since February 2010 -- Compartment B -- Eligible for the Deferred Settlement Service, long only. MEDICA is included in the SBF 120, Euronext CAC Healthcare, MSCI France Small Cap and Gaia indices.
Want to inform investors similar to MEDICA about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Research containing MEDICA
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned MEDICA in 1 CB Insights research brief, most recently on Mar 26, 2020.
Latest MEDICA News
Mar 16, 2023
MEDICA 2022 success promotes demand for 2023 16 March 2023 × Im Rahmen der weltgrößten Medizinmesse MEDICA informieren sich mehr als 120.000 Fachleute, davon 60 Prozent internationale Besucher, über Innovationen und Weiterentwicklungen aus allen Bereichen der ambulanten und stationären Versorgung. Mehr als 5.000 Aussteller aus 66 Nationen präsentieren sich zur MEDICA 2018. http://www.medica.de. | More than 5,000 exhibitors from 66 countries will be showcasing their products and services at MEDICA 2018. Clearly structured, with each market segment assigned its own exhibition hall, MEDICA covers the entire range of medical equipment needs in practices and hospitals. http://www.medica-tradefair.com MEDICA 2022 once again proved to be a vital shop window, innovation hub and networking event for the life sciences and healthcare sector, where companies in this dynamic, fast-moving industry can meet, collaborate, and establish relationships to help to meet the evolving needs of the market. A prominent presence The Medilink UK pavilion located in hall 16 brought significant footfall to exhibitors. Jack Jakins, senior marketing executive at Team Consulting said: “Medilink had a fantastic stand location within the UK pavilion. We had excellent footfall across each day and many useful conversations.” 2022 saw Medilink UK host its largest ever UK pavilion, accommodating some 60 companies wishing to expand their international presence, and supporting a further 40 companies attending trade missions with the Department for International Trade (DIT) from the North of England and Midlands regions. Their presence has grown year on year over the last two decades, becoming the lead UK Partner of the Messe Düsseldorf. Medilink’s pavilion included medtech companies focused on entering new international markets, finding distributors, and establishing new partnerships. Exhibitors included digital health companies, manufacturers of implants and prostheses; producers of medical instruments and consumables; suppliers of diagnostic, treatment, and monitoring systems; and legal, financial, insurance and consulting services. Before the 2022 show had closed, a record number of repeat bookings were being taken for the 2023 event, from both exhibitors new to the show, and those who are regularly a part of MEDICA. Lee Kirk, head of sales at LEEC Limited said: “We exhibited at MEDICA a few years ago to launch new products in our range – the success of which helped us to expand as a business. We exhibited again in 2022 to meet new and existing contacts face-to-face following the COVID-19 pandemic, to obtain more global distribution partners. We met with people from as far as the Middle East and Indonesia and will definitely return to exhibit again.” Comprehensive support Medilink UK’s exhibition package includes access to funding for eligible businesses, support throughout the event, including briefings, meetings with DIT advisors, assistance with travel, shipping and accommodation and networking opportunities. It also includes specialist in-market PR support. For many companies this is a vital aspect of their participation. Peter Carroll, director at Medezine said: “We have worked with Medilink for 15 years on a number of occasions; their exhibition assistance is excellent, with everything from accommodation support to their links with the Department for International Trade for additional opportunities for UK exporters.” Medilink’s innovation and commercialisation specialists were also on hand to offer market insight and guidance to help increase the probability of commercial success and profitability. Advisors are also available to provide information and help with understanding international healthcare settings including market access and opportunities, market dynamics, assessment criteria, reimbursement policies and regulatory landscapes. 2023 opportunities Bookings for this year’s show are now being taken with many exhibitors already signed up, showing that 2023 is set to be another huge, successful event. The Medilink UK pavilion will once again occupy a prominent position in one of the busiest halls. For those wishing to be part of the Medilink UK delegation with associated support and assistance, it’s recommended contacting us as soon as possible to avoid disappointment as space regularly sells out quickly.
MEDICA acquired 1 company. Their latest acquisition was Senior Living Group on September 30, 2013.
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.